CHEK2 and neoplasm: Replacing ATMi, inhibitor of Chk2, a phosphorylation target of ATM, showed similar synergistic inhibition of shGFP H1975 cell (Combination Index: 0.5) and tumor growth of cells (Fig. S8A-E).